Ovanlig genetisk sjukdom behandlad i livmodern för första gången

Ett barn har för första gången behandlats mot spinal muskelatrofi redan i magen på sin mamma. Barnet, som nu är två och ett halvt år gammalt, visar inga symptom...

Dubbla bakslag för ALS-projekt – ”Inte vad vi hoppats på”

Förhoppningarna om att utveckla en ny typ av behandling mot nervsjukdomen ALS har fått sig en törn när två läkemedelskandidater misslyckats med att nå sina prim...

Orexo avslutar partnerskap kring digital depressionsterapi

Det svenska läkemedelsbolaget Orexo har beslutat att inte satsa vidare på stödprogrammet vid depression, Deprexis, på den amerikanska marknaden. Avtalet med den...

Revealing the secrets of a part

CT inspection in automation technology at Festo.

Integrated solutions for liquid handling

Greater efficiency for manufacturers in laboratory automation and many other industries

Artificial intelligence in radiology – “Risk prediction is very exciting”

A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiolog...

“Conducting research at universities is becoming more and more like working at a research hotel”

The government wants Swedish research to focus on excellence and innovation, but can the two be combined? Life Science Sweden talks to Anna Falk, a professor at...

The new ZEISS Celldiscoverer 7 has been launched

Adaptable automation for advanced workflows.

Wusson Accelerator AB

Achieve Efficient, Fast Targeting of Your Sample

Step into the future of imaging technology with VersaXRM 730.

Introducing ZEISS arivis Pro 4.2

ZEISS arivis software enhances custom microscopy image analysis.

CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”

become disease-free, at least of those treated with Yescarta, which are the ones I know best,” says Gunilla Enblad, Chairman of the national working group for CAR-T treatment.

Total pipeline of pharmaceutical companies reaches a record high – 22,921 medicines are currently being developed

Despite the difficult economic times, pharmaceutical companies have never developed as many new drugs as now.

Sofia Wallström is Lif's new CEO

Sofia Wallström has been appointed as the new CEO of the industry organization Lif, the trade association for the research-based pharmaceutical industry in Sweden.

Suing the company – for NOT developing a new HIV drug

Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a lega...

Reveal the Structures and Functions of Life

Super-resolution microscopes from ZEISS.

New features in ZEISS CALYPSO 2024

ZEISS CALYPSO is your universal software for dimensional metrology applications.

Jätteanslag till medicinsk grundforskning – åtta projekt delar på 227 miljoner

Mekanismerna bakom kronisk smärta, en atlas över tarmbarriären och B-cellsminnets outforskade dimensioner är några av de åtta grundforskningsprojekt inom medici...

Forskaren in Hagastaden now inagurated

The real estate company Vectura's life science center in Hagastaden, Forskaren, is now inaugurated. The opening was attended by people from the industry, politi...

Ny säljchef på GBA Key2Compliance

Konsultbolaget Key2compliance har rekryterat Anders Jeppson som ny Director of Sales och nu bytt namn till GBA Key2compliance som en följd av att GBA Group tidi...

Happy International Women's Day!

This March, we're dedicating Fridays to spotlight women in STEM. The first article is about Helena, a Sales Engineer in Sweden. Read why she likes to work with technical sales here....

A mass flow controller that is silent, fast and cost-effective

Portable ventilator breathing devices, bioreactors or the dosing of inert gases all rely on the highest control dynamics. That is exactly what the proportional ...

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

Improved processes and more

Discover the full potential and benefits.